Two Leading Biotech-Pharma Patent Lawyers Join King & Spalding

SILICON VALLEY, CA--(Marketwire - May 28, 2008) - King & Spalding, a leading international law firm, continues to add top talent to its growing intellectual property practice, hiring two new partners in the firm's Silicon Valley office, Peter Dehlinger, Ph.D. and Judy M. Mohr, Ph.D.

"Peter and Judy add important depth to our biotech-pharma practice, which is a strategic initiative for the firm," said Robert Hays, Chairman of King & Spalding. "Their high-value practice complements our leading patent litigation, FDA, product liability and toxic tort, and special matters practices nationwide."

Dehlinger has more than 27 years of patent experience, and is considered a leader of the biotech-pharma bar in Silicon Valley. Dehlinger has a Ph.D. in biophysics from Stanford University, and a J.D. from Lewis & Clark Law School. His expertise includes many areas of biotechnology and physics such as molecular biology, pharmaceutical chemistry, drug delivery systems, diagnostics, instrumentation, thin-film media, robotics, solid-state devices, microfluidics and microfabrication.

Mohr has more than 15 years of experience in life sciences patent procurement, strategic counseling, and portfolio management for emerging as well as mature life science companies. Mohr has a Ph.D. in Chemical Engineering from the University of Texas, and a J.D., cum laude, from Santa Clara University School of Law. She has particular expertise in therapeutics, molecular biology, immunology, proteomics, diagnostics, drug delivery systems, liposomal technology, microarray technology, gas and liquid separations, small molecules and materials science.

"Peter and Judy are leaders in the patent bar, and their addition to our team underscores King & Spalding's commitment to building a preeminent biotechnology, pharmaceutical and medical devices practice in California," said Courtland L. Reichman, who is leader of King & Spalding's intellectual property practice and is relocating to become managing partner of its California offices. King & Spalding's Silicon Valley office will have approximately 25 lawyers and patent agents in its first six months of operation with the addition of Dehlinger, Mohr, the group expected to follow them, and other recent relocations and additions.

King & Spalding's intellectual property practice group consists of more than 100 lawyers and patent agents, including 23 Ph.D.s in the life sciences, in the firm's offices in Atlanta, Charlotte, Houston, New York, San Francisco, Silicon Valley, and Washington, D.C. The group houses a "full service" intellectual property practice, with a focus on patent litigation and prosecution, as well as trademark, false advertising, and other IP disciplines critical to our clients' business. The firm has a particular emphasis on high-tech and biotech-pharma patent litigation, representing several of the country's leading technology companies.

King & Spalding opened its Silicon Valley office in February 2008, in response to strong client demand, with the addition of partners Paul Andre and Lisa Kobialka, and seven associates who specialize in patent litigation, as well as the relocation of firm lawyers specializing in FDA counseling and emerging company corporate work. The firm opened its San Francisco office in March 2008 with the additions of leading product liability litigators, partners Fritz Zimmer and Brenda Buonaiuto.

About King & Spalding

King & Spalding is an international law firm with more than 800 lawyers in Atlanta, Austin, Charlotte, Dubai, Frankfurt, Houston, London, New York, Riyadh (affiliated office), San Francisco, Silicon Valley and Washington, D.C. The firm represents half of the Fortune 100 and in a Corporate Counsel survey in September 2007 was among the top firms representing Fortune 250 companies. For additional information, visit www.kslaw.com.

Contact Information: Contact: Kimberly Brooks King & Spalding 212-827-4378